# iRhythm Holdings, Inc. (IRTC)

> Cited company facts from SEC filings, by Steadybase. Web page: https://steadybase.io/company/irhythm-holdings-inc/ JSON: https://steadybase.io/company/irhythm-holdings-inc.json Checked Nov 10, 2026. Latest filing read: Nov 5, 2026.

## Company

- Legal name: iRhythm Holdings, Inc.
- Ticker: IRTC (Nasdaq)
- SEC CIK: 0001388658
- Industry: Surgical & Medical Instruments & Apparatus (SIC 3841)
- Headquarters: San Francisco, CA
- Fiscal year ends: December 31
- SEC filer category: Large accelerated filer
- Website: irhythmtech.com
- LinkedIn: https://www.linkedin.com/company/irhythm-technologies-inc-
- Next earnings date: Nov 12, 2026 (estimated from past 8-K timing)

## Key facts

- Revenue: $747.1M for the fiscal year ended Dec 31, 2025 (10-K filed Feb 19, 2026). Source: https://www.sec.gov/Archives/edgar/data/1388658/000138865826000011/0001388658-26-000011-index.html
- Operating income: -$57.4M for the fiscal year ended Dec 31, 2025 (10-K filed Feb 19, 2026). Source: https://www.sec.gov/Archives/edgar/data/1388658/000138865826000011/0001388658-26-000011-index.html
- Net income: -$44.6M for the fiscal year ended Dec 31, 2025 (10-K filed Feb 19, 2026). Source: https://www.sec.gov/Archives/edgar/data/1388658/000138865826000011/0001388658-26-000011-index.html
- SG&A: $492.6M for the fiscal year ended Dec 31, 2025 (10-K filed Feb 19, 2026). Source: https://www.sec.gov/Archives/edgar/data/1388658/000138865826000011/0001388658-26-000011-index.html
- Employees: 2,400 as of Dec 31, 2025, as reported in an SEC filing. Source: https://www.sec.gov/Archives/edgar/data/1388658/000138865826000011/irtc-20251231.htm
- Shares outstanding: 33,618,146 as of Oct 29, 2026 (10-Q filed Nov 5, 2026). Source: https://www.sec.gov/Archives/edgar/data/1388658/000138865826000094/0001388658-26-000094-index.html
- Auditor: Pricewaterhousecoopers LLP, San Jose, California, named in the latest 10-K. Source: https://www.sec.gov/Archives/edgar/data/1388658/000138865826000011/irtc-20251231.htm

## Business

iRhythm is a leading digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Our principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that we believe allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology.

Source: Item 1. Business, https://www.sec.gov/Archives/edgar/data/1388658/000138865826000011/irtc-20251231.htm

## Annual results

| Fiscal year ended | Revenue | Operating income | Net income | SG&A |
|---|---|---|---|---|
| Dec 31, 2025 | $747.1M | -$57.4M | -$44.6M | $492.6M |
| Dec 31, 2024 | $591.8M | -$115.5M | -$113.3M | $418.6M |
| Dec 31, 2023 | $492.7M | -$125.2M | -$123.4M | $385.6M |
| Dec 31, 2022 | $410.9M | -$113.8M | -$116.2M | $322.2M |
| Dec 31, 2021 | $322.8M | -$99.9M | -$101.4M | $274.8M |

Each figure comes from the annual report for that year. Filing links for every figure: https://steadybase.io/company/irhythm-holdings-inc.json

## Officers and directors

- Quentin S. Blackford, President and CEO. Source: Form 4 filed Aug 11, 2026, https://www.sec.gov/Archives/edgar/data/1388658/000161245126000012/0001612451-26-000012-index.htm
- Daniel G. Wilson, Chief Financial Officer. Source: Form 4 filed Sep 3, 2026, https://www.sec.gov/Archives/edgar/data/1388658/000186074526000008/0001860745-26-000008-index.htm
- Brice Bobzien, former Chief Financial Officer. LinkedIn: https://linkedin.com/in/brice-bobzien-cpa-05751113. Source: 10-K filed Feb 19, 2026, https://www.sec.gov/Archives/edgar/data/1388658/000138865826000011/irtc-20251231.htm
- Chad Patterson, CHIEF COMM & PRODUCT OFFICER. LinkedIn: https://linkedin.com/in/chadpatterson. Source: Form 4 filed Aug 11, 2026, https://www.sec.gov/Archives/edgar/data/1388658/000185015226000012/0001850152-26-000012-index.htm
- Minang Turakhia, CHIEF MED/SCI OFCR EVP ADVTECH. Source: Form 4 filed Aug 11, 2026, https://www.sec.gov/Archives/edgar/data/1388658/000193268226000012/0001932682-26-000012-index.htm
- Sumi Shrishrimal, EVP, Chief Risk Officer. LinkedIn: https://linkedin.com/in/sumi-shrishrimal-cpa. Source: Form 4 filed Aug 11, 2026, https://www.sec.gov/Archives/edgar/data/1388658/000185068726000010/0001850687-26-000010-index.htm
- Julianne Rodda, EVP, CHIEF PEOPLE OFFICER. Source: Form 4 filed Aug 4, 2026, https://www.sec.gov/Archives/edgar/data/1388658/000212572526000004/0002125725-26-000004-index.htm
- Mervin Smith, EVP Strategic Business Ops. LinkedIn: https://linkedin.com/in/mervinsmith. Source: Form 4 filed Aug 4, 2026, https://www.sec.gov/Archives/edgar/data/1388658/000198521726000012/0001985217-26-000012-index.htm
- Sean Clinton Freeman, EVP, Strategy & Corp Devt. Source: Form 4 filed Jul 6, 2026, https://www.sec.gov/Archives/edgar/data/1388658/000207466126000006/0002074661-26-000006-index.htm
- Marc Wade Rosenbaum, Chief Accounting Officer. Source: Form 4 filed Jun 3, 2026, https://www.sec.gov/Archives/edgar/data/1388658/000192953526000011/0001929535-26-000011-index.htm
- Brian Lee Lawrence, Chief Technology Officer. Source: Form 4 filed May 5, 2026, https://www.sec.gov/Archives/edgar/data/1388658/000150622826000004/0001506228-26-000004-index.htm
- Marc Rosenbaum, SVP, Chief Accounting Officer. LinkedIn: https://linkedin.com/in/marc-rosenbaum-8192198. Source: 10-K filed Feb 19, 2026, https://www.sec.gov/Archives/edgar/data/1388658/000138865826000011/irtc-20251231.htm
- Mark Day, former Chief Technology Officer. Source: 10-K filed Feb 19, 2026, https://www.sec.gov/Archives/edgar/data/1388658/000138865826000011/irtc-20251231.htm
- Mintu Turakhia, Chief Medical Officer, Chief Scientific Officer, and Executive Vice President of Advanced Technologies. Source: 10-K filed Feb 19, 2026, https://www.sec.gov/Archives/edgar/data/1388658/000138865826000011/irtc-20251231.htm
- Karen McGinnis, chair of the Audit Committee. Source: 8-K filed Aug 13, 2026, https://www.sec.gov/Archives/edgar/data/1388658/000138865826000076/irtc-20260811.htm
- Patrick Michael Murphy, CBO and CLO. Source: Form 4 filed Aug 11, 2026, https://www.sec.gov/Archives/edgar/data/1388658/000169278526000009/0001692785-26-000009-index.htm
- C. Noel Bairey Merz, M.D., director. Source: 8-K filed May 28, 2026, https://www.sec.gov/Archives/edgar/data/1388658/000138865826000049/irtc-20260527.htm
- Bruce Bodaken, Director. Source: 10-K filed Feb 19, 2026, https://www.sec.gov/Archives/edgar/data/1388658/000138865826000011/irtc-20251231.htm
- Abhijit Talwalkar, Board member (per proxy). Source: DEF 14A filed Apr 17, 2026, https://www.sec.gov/Archives/edgar/data/1388658/000138865826000030/irtc-20260417.htm
- Brian Lawrence, Named in proxy. LinkedIn: https://linkedin.com/in/bllawrence. Source: DEF 14A filed Apr 17, 2026, https://www.sec.gov/Archives/edgar/data/1388658/000138865826000030/irtc-20260417.htm
- Daniel Wilson, Named in proxy. LinkedIn: https://linkedin.com/in/daniel-wilson-1375996. Source: DEF 14A filed Apr 17, 2026, https://www.sec.gov/Archives/edgar/data/1388658/000138865826000030/irtc-20260417.htm
- Jason Patten, Board member (per proxy). Source: DEF 14A filed Apr 17, 2026, https://www.sec.gov/Archives/edgar/data/1388658/000138865826000030/irtc-20260417.htm
- Julie Rodda, Named in proxy. LinkedIn: https://linkedin.com/in/julierodda. Source: DEF 14A filed Apr 17, 2026, https://www.sec.gov/Archives/edgar/data/1388658/000138865826000030/irtc-20260417.htm
- Karen Ling, Board member (per proxy). Source: DEF 14A filed Apr 17, 2026, https://www.sec.gov/Archives/edgar/data/1388658/000138865826000030/irtc-20260417.htm
- Kevin O'Boyle, Board member (per proxy). Source: DEF 14A filed Apr 17, 2026, https://www.sec.gov/Archives/edgar/data/1388658/000138865826000030/irtc-20260417.htm

## Recent 8-K events

- Nov 5, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1388658/000138865826000093/irtc-20261105.htm
- Oct 5, 2026: Item 7.01, Regulation FD disclosure; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1388658/000138865826000083/irtc-20261005.htm
- Sep 22, 2026: Item 7.01, Regulation FD disclosure. Source: https://www.sec.gov/Archives/edgar/data/1388658/000138865826000080/irtc-20260922.htm
- Aug 13, 2026: Item 5.02, Departure or appointment of directors or officers; compensation. Source: https://www.sec.gov/Archives/edgar/data/1388658/000138865826000076/irtc-20260811.htm
- Aug 6, 2026: Item 1.01, Entry into a material definitive agreement; Item 3.02, Unregistered sales of equity securities; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1388658/000138865826000071/irtc-20260805.htm
- Aug 6, 2026: Item 1.01, Entry into a material definitive agreement; Item 2.02, Results of operations and financial condition (earnings release); Item 7.01, Regulation FD disclosure; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1388658/000138865826000070/irtc-20260731.htm
- Jun 15, 2026: Item 1.05, Material cybersecurity incident. Source: https://www.sec.gov/Archives/edgar/data/1388658/000138865826000055/irtc-20260610.htm
- Jun 5, 2026: Item 7.01, Regulation FD disclosure; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1388658/000138865826000052/irtc-20260603.htm
- May 28, 2026: Item 5.02, Departure or appointment of directors or officers; compensation; Item 5.07, Submission of matters to a vote of security holders; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1388658/000138865826000049/irtc-20260527.htm
- Apr 30, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1388658/000138865826000038/irtc-20260430.htm

## Insider trades (Form 4)

- Sep 2, 2026: Daniel G. Wilson (Chief Financial Officer) sold 773 shares, about $94,175. Source: https://www.sec.gov/Archives/edgar/data/1388658/000186074526000008/0001860745-26-000008-index.htm
- Aug 10, 2026: Minang Turakhia (CHIEF MED/SCI OFCR EVP ADVTECH) sold 7,093 shares, about $884,142. Source: https://www.sec.gov/Archives/edgar/data/1388658/000193268226000012/0001932682-26-000012-index.htm
- Aug 10, 2026: Sumi Shrishrimal (EVP, Chief Risk Officer) sold 5,372 shares, about $669,620. Source: https://www.sec.gov/Archives/edgar/data/1388658/000185068726000010/0001850687-26-000010-index.htm
- Aug 10, 2026: Chad Patterson (CHIEF COMM & PRODUCT OFFICER) sold 7,093 shares, about $884,142. Source: https://www.sec.gov/Archives/edgar/data/1388658/000185015226000012/0001850152-26-000012-index.htm
- Aug 10, 2026: Patrick Michael Murphy (CBO and CLO) sold 7,093 shares, about $884,142. Source: https://www.sec.gov/Archives/edgar/data/1388658/000169278526000009/0001692785-26-000009-index.htm
- Aug 10, 2026: Quentin S. Blackford (President and CEO) sold 26,859 shares, about $3.3M. Source: https://www.sec.gov/Archives/edgar/data/1388658/000161245126000012/0001612451-26-000012-index.htm
- Aug 3, 2026: Julianne Rodda (EVP, CHIEF PEOPLE OFFICER) sold 2,112 shares, about $257,917. Source: https://www.sec.gov/Archives/edgar/data/1388658/000212572526000004/0002125725-26-000004-index.htm
- Aug 3, 2026: Mervin Smith (EVP Strategic Business Ops) sold 617 shares, about $75,348. Source: https://www.sec.gov/Archives/edgar/data/1388658/000198521726000012/0001985217-26-000012-index.htm
- Aug 3, 2026: Chad Patterson (CHIEF COMM & PRODUCT OFFICER) sold 2,712 shares, about $331,189. Source: https://www.sec.gov/Archives/edgar/data/1388658/000185015226000010/0001850152-26-000010-index.htm
- Jul 2, 2026: Sean Clinton Freeman (EVP, Strategy & Corp Devt) sold 918 shares, about $114,484. Source: https://www.sec.gov/Archives/edgar/data/1388658/000207466126000006/0002074661-26-000006-index.htm
- Jul 2, 2026: Minang Turakhia (CHIEF MED/SCI OFCR EVP ADVTECH) sold 1,423 shares, about $177,462. Source: https://www.sec.gov/Archives/edgar/data/1388658/000193268226000010/0001932682-26-000010-index.htm
- Jun 2, 2026: Marc Wade Rosenbaum (Chief Accounting Officer) sold 729 shares, about $78,871. Source: https://www.sec.gov/Archives/edgar/data/1388658/000192953526000011/0001929535-26-000011-index.htm
- Jun 2, 2026: Sumi Shrishrimal (EVP, Chief Risk Officer) sold 1,716 shares, about $185,654. Source: https://www.sec.gov/Archives/edgar/data/1388658/000185068726000008/0001850687-26-000008-index.htm
- May 11, 2026: Abhijit Y. Talwalkar (Director) sold 5,312 shares, about $626,438. Source: https://www.sec.gov/Archives/edgar/data/1388658/000131606526000007/0001316065-26-000007-index.htm
- May 11, 2026: Abhijit Y. Talwalkar (Director) bought 5,312 shares, about $56,892. Source: https://www.sec.gov/Archives/edgar/data/1388658/000131606526000007/0001316065-26-000007-index.htm

## What management said

- "Our third quarter results reflect the continued strength of our core business. Demand for Zio Monitor remains robust, exceeding our expectations in the quarter, driven by volume growth across care settings and channels. We also continued to take meaningful steps forward with significant margin expansion, and consistent execution against our strategic priorities" Quentin Blackford, President and Chief Executive Officer of iRhythm (8-K filed Nov 5, 2026). Source: https://www.sec.gov/Archives/edgar/data/1388658/000138865826000093/irtcq32026ex991pressrelease.htm

## Latest filings

- 8-K filed Oct 5, 2026: https://www.sec.gov/Archives/edgar/data/1388658/000138865826000083/irtc-20261005.htm
- 10-K filed Feb 19, 2026: https://www.sec.gov/Archives/edgar/data/1388658/000138865826000011/irtc-20251231.htm
- 10-Q filed Aug 6, 2026: https://www.sec.gov/Archives/edgar/data/1388658/000138865826000072/irtc-20260630.htm
- DEF 14A filed Apr 17, 2026: https://www.sec.gov/Archives/edgar/data/1388658/000138865826000030/irtc-20260417.htm

## About this data

SEC EDGAR filings, read by Steadybase. Every value links to the filing it came from.
Steadybase covers US-headquartered public companies that file with the SEC. API and MCP access: https://steadybase.io/docs/